Silvia Argimón retweeted
Today, the International Pathogen Surveillance Network, hosted by the @WHO Hub in Berlin, launched US$ 1.8 million in catalytic grants to strengthen genomic, wastewater & environmental surveillance in low -and- middle-income countries
More info to apply: bit.ly/WHOIPSNfunding
Please join us for the EPI-WIN webinar introducing @WHO 's report on Attributes and Principles of Pathogen Genomic Data-Sharing Platforms. 24/11/25, 1-2pm CET.
🔗 Register: who.zoom.us/webinar/register…
👉 Webinar info: who.int/news-room/events/det…
📄 Report: iris.who.int/bitstreams/fd9e…
Silvia Argimón retweeted
Are you interested in learning how pathogen genomics is used to understand mpox transmission dynamics & strengthen public health interventions?
Don’t miss the next International Pathogen Surveillance Network #IPSN webinar
🗓️ 16 Apr, 1PM CEST
Register: bit.ly/4izgco4
📢 There is one week left to participate in WHO's online consultation on the critical features of pathogen genomic data-sharing platforms to meet public health needs. Thank you to all those who have already submitted their feedback.
Are you working in #PathogenGenomics?
Participate in @WHO's online consultation on the critical features of pathogen genomic data-sharing platforms to meet public health needs.
All info here: bit.ly/4jiUENe
Silvia Argimón retweeted
Are you working in #PathogenGenomics?
Participate in @WHO's online consultation on the critical features of pathogen genomic data-sharing platforms to meet public health needs.
All info here: bit.ly/4jiUENe
Silvia Argimón retweeted
We are hiring remote bioinformaticians at @theiagen . If you have a passion for microbial bioinformatics or public health, send your CV to [email protected] . You can be based nearly anywhere but need to be available to work US business hours.
Silvia Argimón retweeted
Please join us at 13:00 CET December 12th for the next edition of the IPSN webinar series 'Pathogen Genomics in Health Emergencies' to hear how genomics can contribute to the understanding of Cholera outbreaks. Register here:
Silvia Argimón retweeted
Intl Pathogen Surveillance Network #IPSN coordinated by @WHO holds Global Partners Forum in Bangkok, co-hosted by @WHOSEARO @WHOWPRO & @TheDohertyInst
#IPSN partners collaborate to drive innovation in #PathogenGenomic to strengthen decision-making
➡️bit.ly/WHOIPSN
Silvia Argimón retweeted
We announced the 1st round recipients of the @WHO Intl Pathogen Surveillance Network #IPSN catalytic grant fund at the Global Partners Forum in Bangkok
Excited for this inspiring group to pilot innovative approaches to #PathogenGenomics in LMICs
➡️ bit.ly/3Z7kBpR
Silvia Argimón retweeted
WHO study lists top endemic pathogens for which new vaccines are urgently needed @WHO who.int/news/item/05-11-2024…
Learn how to effectively utilise AMR genotype-phenotype databases through this free online course starting on September 30th.
We are running a massive online open course on AMR databases starting end of the month. Its completely free, study at your own pace and its ~15 hours overall over the 3 weeks (although you can finish any time in a year). Please spread in your networks! coursesandconferences.wellco…
Silvia Argimón retweeted
Please join us to hear how genomics is helping in response to the multiple outbreaks of Dengue from the @who hosted International Pathogen Surveillance Network. Register here: echo.zoom.us/webinar/registe…
Silvia Argimón retweeted
Drug-resistant infections are a global problem.
They’re a threat to our health, livelihoods, healthcare systems and national economies.
However, the weight of this burden is not felt equally.
Not even close. ⤵️🌍 [1/3]

ALT Drug-resistant infections threaten us all—but not equally. A world map with regions coloured in various shades of red indicates the number of deaths associated with bacterial antimicrobial resistance (AMR) in 2019. The darkest shades of red show that South Asia, sub-Saharan Africa, Southeast Asia, east Asia and Oceania have the highest number of deaths associated with AMR. High-income countries, as well as Latin America, the Caribbean, Central Europe, eastern Europe, central Asia, North Africa and the Middle East, are notably lighter in colour – showing the lower burden of deaths associated with AMR. A footnote shows the source of information as 'The Lancet, Global burden of bacterial antimicrobial resistance in 2019 report'.
Silvia Argimón retweeted
🚩 Deadline for LMICs travel grants to Paris #KLEBS2024 symposium this end of week 🚩
This Post is from an account that no longer exists. Learn more
Silvia Argimón retweeted
I'm pleased to announce the second edition of our "Working with Bacterial Genomes" course is now open for registration: training.cam.ac.uk/bioinform…
Silvia Argimón retweeted
Africa’s postdoc workforce is on the rise — but at what cost? nature.com/articles/d41586-0…
Silvia Argimón retweeted
Typhoid exerts an untenable burden in Africa. We & other African bacteriologists and ID experts worked with @IVIHeadquarters to study the “Incidence of typhoid fever in 🇧🇫 , 🇨🇩 , 🇪🇹 , 🇬🇭 , 🇲🇬 , & 🇳🇬”. Our findings are just out in @LancetGH thelancet.com/journals/langl……/2
Silvia Argimón retweeted
Melioidosis kills 40% of cases, yet diagnosis remains a challenge. Many patients died before the arrival of a culture-confirmed diagnosis. With @PWongpalee and @TaoUttamapinant, we developed and validated a rapid test for melioidosis👇thelancet.com/journals/lanmi…
Silvia Argimón retweeted
Está abierta la convocatoria para que investigadores jóvenes nos acompañen en la 2nd Minería genómica de productos naturales de Latinoamérica
-
Applications are now open for #ECRs to join us at the 2nd Genome mining of natural products, Latin America 2024
-please use QR code























